We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
This page provides health professionals with information and resources related to access pathways for medicinal cannabis.
Accessing medicinal cannabis for a patient
There are four pathways for accessing 'unapproved' medicinal cannabis products, if you determine that it is clinically suitable for your patient.
- Authorised Prescriber - Established History of Use pathway
- Authorised Prescriber - Standard pathway
- SAS Category A notification pathway
- SAS Category B application pathway
Learn more about the pathways for accessing unapproved medicinal cannabis products.
Applications and reporting
Find out how to make an application using the SAS and Authorised Prescriber Online System. Information on your responsibilities as a prescriber, including consent and reporting is also available.
Learn more about applications and reporting for medicinal cannabis products.
Medicinal cannabis products by active ingredients
To assist health professionals and pharmacists in prescribing and supplying medicinal cannabis products, we've published a list of products by ingredients, dosage form, quantity per dosage unit, and sponsor. These lists should be used where TGA approval has been obtained and the prescriber requires assistance in choosing a product from the correct category.
View the list of medicinal cannabis products by active ingredients.
Resources, clinical trials and clinical evidence
We've published a range of information to help health professionals learn more about medicinal cannabis products, including guidance, videos, external research and clinical evidence.
You can also access information from the Office of Drug Control, if you need to apply for a licence and permission to import.